Table 2. Summary of Findings
|
Author (year) |
Gender, Age |
Case |
Symptoms |
Physical Findings |
Symptom Duration |
Imaging Findings |
Tumor Size (cm) |
Tumor Site |
SSS Invasion |
Extent of Resection |
Histopathological Findings |
WHO Grade |
Intraop Complications |
Postop Complications |
Follow-up duration (mo) |
Outcome (Summary) |
Length of Hospital Stay (days) |
|
Alzughaibi et al., 2024[23] |
M, 57 |
Bilateral parasagittal-falcine meningioma |
Generalized tonic-clonic seizure |
Non-tender bifrontal mass |
2 years |
Anterior falcine mass with vasogenic edema, complete invasion of middle third SSS |
5.7 x 5.3 x 3.1 |
Anterior and middle third |
Yes (complete) |
GTR |
Transitional meningioma |
I |
None |
Swelling due to a serum collection, resolved with aspiration |
3 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
Hassan et al., 2024[24] |
F, 70 |
Cystic falcine meningioma |
Disorganized speech and aggression |
Muscle weakness in the lower limbs |
3 months |
Bilateral frontal cystic mass, resembling a cystic lesion |
8.41 × 6.67 × 7.30 |
Anterior third falcine |
Yes (partial) |
GTR |
Meningothelial meningioma |
I |
None |
None |
12 |
Symptoms improve, no neurological deficits, or recurrent tumor |
3 |
|
Papadimitriou et al., 2020[26] |
F, 55 |
Falcine meningioma |
Generalized tonic-clonic seizure |
No other neurological deficits |
NR |
Large, highly vascular anterior falcine meningioma with aneurysms |
"large" |
Anterior third falcine |
No |
Embolization and GTR |
Meningothelial meningioma |
I |
None |
None |
36 |
No neurological symptoms/deficit, no residual aneurysm, or recurrent tumor |
NR |
|
Kiat et al., 2018[25] |
M, 33 |
Falcine meningioma |
Progressive behavioural changes, poor memory, and social isolation over the past ten years |
Bilateral papilledema, lower limbs power was 4/5, hypertonia, and hypereflexia |
10 years |
Homogeneously enhancing falcine meningioma |
7cm X 7.5cm X 7.5cm |
Middle third |
No |
GTR |
NR |
I |
None |
Transient worsening of frontal lobe syndrome, subsided after three days |
12 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
Psaras et al., 2009[27] |
F, 49 |
Falcine meningioma (lung metastases) |
History of frequent headaches and nausea |
Hemiparesis on the right side |
NR |
Partially calcified parietal meningioma involving falx and SSS |
6 × 4 × 3 cm |
Middle third |
Yes (complete) |
STR and GTR (2nd op) |
Meningothelial meningioma |
I |
Invasive character with firm adherence to the arachnoid space and venous bleeding from SSS |
None |
180 |
Symptoms improve and Recurrent |
NR |
|
|
|
Residual tumor of the parietal falcine meningioma with multiple lung metastases |
Persistent dry cough |
No other neurological deficits |
NR |
Residual parietal falx meningioma with complete sagittal sinus occlusion; bilateral lung lesions suspicious for metastases |
"same" |
|
|
|
Meningothelial meningioma (Metastases) |
|
None |
|
12 |
Symptoms improve, no residual tumor or metastasis detected |
5 |
|
Kusdiansah et al., 2023[28] |
F, 55 |
Falcine meningioma |
Worsening headaches and acute nausea |
4/5 left-sided hemiparesis |
NR |
Large right paramedian meningioma with enlarged diploic veins bypassing occluded SSS |
6.3 x 4.6 x 6.8 cm |
NR |
Yes (complete) |
Near-total resection |
NR |
NR |
None |
None |
2 |
Symptoms improve, but a residual tumor is still detected |
5 |
|
Gotohda et al., 2024[14] |
F, 64 |
Hemorrhagic falcine meningiomas |
Headache and weakness in the right lower limbs |
No other neurological deficits |
4 days |
Hyperintensity, dural tail, subacute hemorrhage |
5.0 × 3.6 × 4.0 cm |
Anterior third |
No |
NR |
Transitional meningioma |
I |
None |
None |
NR |
Patients exhibited only slight muscle weakness in the right upper and lower extremities, but remained stable |
22 |
|
Mathuriya et al., 2000[29] |
M, 60 |
Calcified falcine Meningioma |
Left focal seizures (tingling and numbness of the lower limb, and then progressed to the upper limb) and tonic-clonic movements. |
Mild left spastic hemiparesis (power 4/5) with cortical sensory impairment |
3 months |
Right posterior parietal calcified mass with central homogeneity and peripheral heterogeneity |
7 x 5 cm |
Middle third |
NR |
GTR |
Meningothelial meningioma |
I |
None |
None |
18 |
Symptoms improve. The patient had a focal seizure controlled with phenobarbitone and phenytoin, and no recurrent tumor |
NR |
|
Karthigeyan et al., 2018[30] |
M, 46 |
Bifalcine meningiomas |
Raised ICP, weakness of limbs (L>R) |
NR |
NR |
Large bilateral dumbbell/globular tumors extending symmetrically into both cerebral hemispheres |
7.6 × 5.4 × 5.2 |
Anterior third |
NR |
GTR |
Meningothelial meningioma |
I |
None |
None |
17 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
M, 58 |
Bifalcine meningiomas |
Weakness of left lower limb |
NR |
NR |
Large bilateral dumbbell/globular tumors extending symmetrically into both cerebral hemispheres |
6.1 × 5.5 × 5.3 |
Anterior third |
NR |
GTR |
Meningothelial meningioma |
I |
None |
None |
7 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
|
F, 70 |
Bifalcine meningiomas |
Walking difficulty, urinary incontinence |
NR |
NR |
Large bilateral dumbbell/globular tumors extending symmetrically into both cerebral hemispheres |
6.8 × 5.8 × 5.4 |
Anterior third |
NR |
Near total resection |
Meningothelial meningioma |
I |
None |
None |
8 |
Symptoms improve, but still a residual tumor detected |
NR |
|
|
F, 55 |
Bifalcine meningiomas |
Headache, left hemiparesis |
NR |
NR |
Large bilateral dumbbell/globular tumors extending symmetrically into both cerebral hemispheres |
7.2 × 5.6 × 5.5 |
Anterior third |
NR |
GTR |
Meningothelial meningioma |
I |
None |
None |
4 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
|
F, 52 |
Bifalcine meningiomas |
Headache, subtle right-sided weakness, |
NR |
NR |
Large bilateral dumbbell/globular tumors extending symmetrically into both cerebral hemispheres |
7.5 × 6.5 × 6 |
Posterior third |
NR |
GTR |
Meningothelial meningioma |
I |
None |
None |
10 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
|
Otani et al., 2018[9] |
M, 74 |
Falcine meningioma |
Numbness of the right lower extremity and right homonymous hemianopia |
No other neurological deficits |
NR |
Mass in the middle third falx with homogeneous enhancement; adjacent bridging veins including Rolandic vein |
6 cm |
Middle third |
No |
GTR |
NR |
NR |
None |
None |
60 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
F, 58 |
Falcine meningioma |
Left lower extremity weakness and hemianopia |
No other neurological deficits |
NR |
Extra-axial falx mass, homogeneous enhancement in middle third |
7 cm |
Middle third |
No |
GTR |
NR |
NR |
None |
None |
36 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
|
Bederson et al., 1995[15] |
F, 62 |
Bilateral Parasagittal meningioma |
Headache without significant medical history |
No other neurological deficits |
NR |
Large right parasagittal meningioma with adjacent edema and contralateral small lesion; SSS occlusion |
8 cm |
Posterior third |
yes (partial) |
GTR with reconstruction of the sinus (saphenous vein graft) |
NR |
NR |
The tumor attach along the lateral wall of the sagittal sinus and could not be resected entirely because of bleeding from the sinus. |
None |
9 |
Symptoms improve, no neurological deficits, or recurrent tumor |
9 |
|
Aboud et al., 2021[13] |
M, 39 |
Parasagittal meningioma |
Headache and palpable mass on the skull |
Parietal palpable subcutaneous mass hard |
NR |
Giant parasagittal meningioma invading sagittal sinus, skull, and subgaleal tissue with collateral drainage via cortical/subcutaneous veins |
"giant" |
Middle third |
Yes (complete) |
GTR with reconstruction of the sinus (saphenous vein graft) |
Atypical meningioma |
II |
None |
None |
NR |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
Walker et al., 2023[16] |
F, 58 |
Parasagittal meningioma |
Intermittent headaches and new-onset seizures |
No other neurological deficits |
NR |
Left parasagittal extra-axial mass with vasogenic edema and lobulated parenchymal margins |
7.3 x 3.2 x 2.1 |
Anterior Middle third |
yes (partial) |
GTR |
Atypical meningioma |
II |
The tumor infiltrates the pia. Additional removal of the tumor to decompress the midline structures was performed. |
Right-sided hemiparesis and global aphasia were present but were successfully managed with high-dose dexamethasone. |
NR |
Symptoms improve, with right-sided apraxia (slight neurological deficits), no recurrent tumor detected. |
NR |
|
Wang et al., 2016[6] |
M, 45 |
Parasagittal meningioma |
Poor memory |
No other neurological deficits |
NR |
NR |
8 |
Anterior third |
Yes (complete) |
GTR |
Trasitional |
I |
NR |
None |
42 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
M, 34 |
Parasagittal meningioma |
Enlargement of a biparietal mass, head and neck pain, and right lower leg weakness |
No other neurological deficits |
7 years |
Large posterior SSS mass with subcutaneous extension, ill-defined, hyperostotic |
11 × 6.6 × 7 cm |
Anterior third |
Yes (complete) |
GTR |
Atypical |
II |
None |
Transient hemiparesis |
34 |
Symptoms improve, no neurological deficits, or recurrent tumor |
15 |
|
|
M, 58 |
Parasagittal meningioma |
Seizure |
No other neurological deficits |
NR |
NR |
9 cm |
Anterior third |
Yes (not clear) |
GTR |
Atypical |
II |
NR |
Transient hemiparesis and epilepsy |
36 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
|
M, 41 |
Parasagittal meningioma |
Recurrence |
No other neurological deficits |
NR |
NR |
7 cm |
Middle third |
Yes (complete) |
GTR |
Meningothelial |
I |
NR |
None |
27 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
|
F, 52 |
Parasagittal meningioma |
Glossolalia |
No other neurological deficits |
NR |
NR |
9 cm |
Middle third |
Yes (complete) |
GTR |
Trasitional |
I |
NR |
Transient hemiparesis |
22 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
|
M, 45 |
Parasagittal meningioma |
Bone neoplasm |
No other neurological deficits |
NR |
NR |
12 cm |
Middle third |
Yes (complete) |
GTR |
Trasitional |
I |
NR |
Hematoma |
17 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
|
F, 49 |
Parasagittal meningioma |
Paroxysmal unconsciousness |
No other neurological deficits |
5 years |
Middle third SSS tumor with sinus occlusion and inferior sagittal sinus enlargement |
7 cm |
Middle third |
Yes (complete) |
GTR |
Trasitional |
I |
NR |
Transient hemiparesis |
18 |
Symptoms improve, no neurological deficits, or recurrent tumor |
26 |
|
|
M, 27 |
Parasagittal meningioma |
Poor memory |
No other neurological deficits |
NR |
NR |
7 cm |
Posterior third |
Yes (complete) |
GTR |
Meningothelial |
I |
NR |
None |
31 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
|
F, 59 |
Parasagittal meningioma |
Recurrence |
No other neurological deficits |
NR |
NR |
10 cm |
Posterior third |
Yes (complete) |
GTR |
Meningothelial |
I |
NR |
paralysis of the two lower limbs. |
43 |
No improvement in Karnofsky performance score |
NR |
|
|
M, 58 |
Parasagittal meningioma |
Recurrence |
No other neurological deficits |
NR |
NR |
7 cm |
Middle third |
Yes (not clear) |
GTR |
Malignant |
III |
NR |
Recurrence |
20 |
Recurrence and the patient died after 2 years |
NR |
|
|
Dimou et al., 2021[17] |
F, 79 |
Falcine meningioma |
Abdominal pain RUQ and right flank, 4 months later, the patient experienced right-sided lower limb weakness and a new footdrop |
Weakness in the right lower limb and altered sensation in the right side of the abdomen and flank. |
9 months |
Large left parafalcine meningioma with significant mass effect on posterior frontal/parietal lobes |
"large" |
Middle third |
No |
NR |
NR |
I |
None |
A partial sensory-motor seizure that was successfully controlled with an anticonvulsant. |
6 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
Savateev et al., 2016[18] |
M, 10 |
Parasagittal meningiomas |
Right-sided hemiparesis and hemihypesthesia resolved with osmodiuretics and glucocorticoids |
Bulging in the parietal region |
11 days |
Parasagittal tumor with intra- and extracranial growth, bone invasion, perifocal edema, and middle third SSS invasion; accompanied by hyperostotic lesion |
11×8.5 cm |
Middle third |
yes (complete) |
The 1st surgery was terminated due to a high blood loss. At the second stage, the intracranial tumor portion was removed, Simpson grade 4. |
Meningotheliomatous meningioma, but the second pathology report was atypical meningioma |
II |
high blood loss and risk of further massive bleeding |
None |
12 |
Symptoms improve, residual tumor detected after 3 months, but no further residual detected after radiation therapy. |
14 |
|
Okunlola et al., 2024[20] |
F, 48 |
Parasagittal cystic meningioma |
Complex partial seizures resistant to anticonvulsants, headache, and right hemibody weakness. |
Motor aphasia, right supranuclear fasciolaris, and right hemiplegia |
6 months |
Left frontal cystic parasagittal tumor with enhancing mural nodule attached to lateral SSS and falx; perilesional edema present |
"large" |
Anterior third |
yes (partial) |
GTR |
Meningothelial meningioma |
I |
None |
None |
6 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
Rajagopal et al., 2022[19] |
F, 27 |
Parasagittal meningioma |
Bilateral headaches, visual changes, and nausea |
Nerve VI palsy and severe papilledema |
6 months |
Left superior frontal parafalcine mass with SSS invasion, homogeneous enhancement, and vasogenic edema, extending near the torcula |
5.1 x 3.8 x 4.1 cm |
Anterior third |
yes (complete) |
GTR |
Atypical meningioma |
II |
None |
None |
18 |
Patient had resolution of all symptoms, no residual or recurrent tumor |
3 |
|
Li et al., 2016[5] |
M, 2 |
Parasagittal meningioma |
Progressive head enlargement and walking difficulties |
Open frontal fontanelle, an occipital-frontal circumference of 56 cm, visual acuity was 6/24 in both eyes, and mild physiologic anisocoria |
6 months |
Large bilateral occipito-temporo-parietal mass with necrosis, occipital bone erosion, and compression of lobes/ventricles; highly vascularized on MRA |
14.2 x 13.5 x 11.1 cm |
Middle and Posterior third |
yes (complete) |
GTR followed by resection of residual tumor |
Atypical meningioma |
II |
The blood pressure decreased to unrecordable levels however, the patient was resuscitated. In the 2nd operation, the patient suffered from two hemorrhagic shocks. |
The patient had a low-grade fever for 10-14 days but was successfully managed with antibiotics and a bilateral subdural hematoma, which resolved after 2 years. |
60 |
Symptoms improve, no neurological deficits, or recurrent tumor |
10 |
|
Honda et al., 2017[21] |
M, 3 |
Falcine Meningioma |
Vomiting, fever, and left-sided weakness |
The patient's consciousness progressively deteriorated |
10 days |
Heterogeneous right frontal mass with intratumoral hemorrhage |
7 cm |
Anterior third and middle third of the falx cerebri |
NR |
GTR, followed by residual tumor resection |
Anaplastic meningioma |
III |
NR |
NR |
4 |
A recurrent tumor was detected but disappeared after radiotherapy. But after 8 months, lung metastasis of anaplastic meningioma occurred. |
NR |
|
Doxtader et al., 2009[22] |
M, 8 |
Parasagittal meningioma |
Headaches, dizziness, involuntary eye flickering, and benign cervical lymphadenopathy |
No other neurological deficits |
3 years |
Multilobulated parasagittal mass, with solid/cystic components, peritumoral edema, and midline shift |
7.5 cm |
Posterior third |
NR |
STR and GTR of recurrent tumor |
Atypical meningioma |
II |
NR |
NR |
NR |
Worsening of symptoms, progressive tumor enlargement, and metastasis |
NR |
|
Wang et al., 2022[7] |
M, 43 |
Parasagittal meningioma |
Calvaria mass |
No other neurological deficits |
1 month |
Parasagittal meningioma infiltrating middle third SSS and adjacent large precentral cerebral vein involvement. |
5.5 cm × 3.4 cm |
Middle third |
yes (complete) |
GTR |
Transitional meningioma |
I |
None |
None |
3 |
Symptoms improve, no neurological deficits, or recurrent tumor |
NR |
|
Abbreviations: GTR, gross total resection; STR, subtotal resection; SSS, superior sagittal sinus; MRI, magnetic resonance imaging; CT, computed tomography; CTV, CT venography; MRA, magnetic resonance angiography; CSF, cerebrospinal fluid; ICP, intracranial pressure; ADL, activities of daily living; MRC, Medical Research Council (muscle strength scale); WHO, World Health Organization; RUQ, right upper quadrant; mo, months; cm, centimeters; NR, not reported; Gy, gray (unit of radiation dose). |
|||||||||||||||||